Results 151 to 160 of about 74,631 (338)
Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesias.
, 1975 Daniel Tarsy +2 more
openalex +1 more source
Movement Disorders Clinical Practice, EarlyView.Abstract Background Parkinson's disease (PD) is a neurodegenerative disorder associated with motor and nonmotor symptoms. Objectives This study assesses levodopa dose management, the therapeutic goals of clinicians, the factors that influence clinicians' choice of therapy, and the role of nonmotor symptoms using real‐world evidence from Germany, Italy,
Fabrizio Stocchi +2 more
wiley +1 more source
Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease
, 1974 J. D. Parkes +3 more
openalex +1 more source
Levodopa-induced dyskinesia and thalamotomy. [PDF]
, 1984 Hirotaro Narabayashi +2 more
openalex +1 more source
Levodopa‐Responsive Dystonia Secondary to CTNNB1 Neurodevelopmental Disorder
Movement Disorders Clinical Practice, EarlyView.
Hanin Algethami +5 more
wiley +1 more source
ABNORMAL INVOLUNTARY MOVEMENTS IN RELATION TO ANTICHOLINERGICS AND LEVODOPA THERAPY
, 1975 Erik Birket-Smith
openalex +1 more source
Abnormal eye-head coordination in Parkinson's disease patients after administration of levodopa: a possible substrate of levodopa-induced dyskinesia. [PDF]
, 1986 Michael Weinrich, Rohit Bhatia
openalex +1 more source
Observed and Patient‐Perceived Information Provision When Diagnosed With Parkinson's Disease
Movement Disorders Clinical Practice, EarlyView.Abstract Background People with Parkinson's disease (PD) perceive to receive insufficient disease‐specific information after diagnosis, whereas clinicians report providing all relevant information. Objectives The objectives were to examine the information actually provided by clinicians during diagnostic consultations and its relations with background ...
Elisabeth Kurpershoek +10 more
wiley +1 more source